Similar articles

• Reasons for delay of endocrine treatment in cancer of the prostate (until symptomatic metastases occur).

  Christensen MM, Aagaard J, Madsen PO. Christensen MM, et al. Prog Clin Biol Res. 1990;359:7-14; discussion 15-24. Prog Clin Biol Res. 1990. PMID: 2284298 Review.
• Combined surgery and immediate adjuvant hormonal treatment for stage D1 adenocarcinoma of the prostate: Mayo Clinic experience.

  Zincke H. Zincke H. Semin Urol. 1990 Aug;8(3):175-83. Semin Urol. 1990. PMID: 2399386 No abstract available.
• Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate.

  Robinson MR. Robinson MR. Prog Clin Biol Res. 1987;243A:383-90. Prog Clin Biol Res. 1987. PMID: 2958863 Clinical Trial. No abstract available.
• Bilateral orchiectomy in the management of stage D-2 prostate cancer.

  Guinan P, Firfer R, Targonski P, Rubenstein M. Guinan P, et al. Int Surg. 1993 Jan-Mar;78(1):73-5. Int Surg. 1993. PMID: 8473090
• The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy.

  Mayer FJ, Crawford ED. Mayer FJ, et al. Urol Clin North Am. 1994 Nov;21(4):707-15. Urol Clin North Am. 1994. PMID: 7974899 Review.